Suchergebnisse - %22Fibrinolytic Agents%22

PubPharm (13)

1

New approaches for the assessment of platelet activation status in thrombus under flow condition using confocal microscopy

enthalten in: Naunyn-Schmiedeberg's archives of pharmacology | 2020

von Marcinczyk, N. | Golaszewska, A. | Misztal, T. | +3

2

Short-term treatment with nitrate is not sufficient to induce in vivo antithrombotic effects in rats and mice

enthalten in: Naunyn-Schmiedeberg's archives of pharmacology | 2017

von Kramkowski, K. | Leszczynska, A. | Przyborowski, K. | +6

3

Studies on the antiplatelet and antithrombotic profile of anti-inflammatory coumarin derivatives

enthalten in: Journal of enzyme inhibition and medicinal chemistry | 2015

von Kontogiorgis, C. | Nicolotti, O. | Mangiatordi, G. | +7

4

Antithrombotic activity of a newly synthesized coumarin derivative 3-(5-hydroxy-2,2-dimethyl-chroman-6-yl)-N-{2-[3-(5-hydroxy-2,2-dimethyl-chroman-6-yl)-propionylamino]-ethyl}-propionamide

enthalten in: Chemical biology & drug design | 2013

von Jain, M. | Surin, W. | Misra, A. | +8

5

Advances in cardiology : clinical trial update

enthalten in: Future cardiology | 2011

von Howe, A. | Shand, J. | Menown, I.

6

Antithrombotic therapy in patients with first-ever stroke and known non-rheumatic atrial fibrillation

enthalten in: Praxis | 2005

von Gandjour, J. | Zeindler, J. | Georgiadis, D. | +1

7

Thromboembolic complications of cancer : epidemiology, pathogenesis, diagnosis, and treatment

enthalten in: American journal of hematology | 2003

von Sutherland, D. | Weitz, I. | Liebman, H.

8

New anthithrombotic drugs

enthalten in: Medicina clinica | 2002

von Martínez Brotons, F.

9

Aspirin plus coumarin versus aspirin alone in the prevention of reocclusion after fibrinolysis for acute myocardial infarction : results of the Antithrombotics in the Prevention of Reocclusion In Coronary Thrombolysis (APRICOT)-2 Trial

enthalten in: Circulation | 2002

von Brouwer, M. | van den Bergh, P. | Aengevaeren, W. | +7

10

Antithrombotic and platelet function inhibiting effects of ML3000, a new antiinflammatory drug with Cox/5-LOX inhibitory activity

enthalten in: Inflammation research : official journal of the European Histamine Research Society ... [et al. | 2002

von Tries, S. | Laufer, S. | Radziwon, P. | +1